|
1
|
Wang W, Yang J, Wang Y, Wang D, Han G, Jia
J, Xu M and Bi W: Survival and prognostic factors in Chinese
patients with osteosarcoma: 13-year experience in 365 patients
treated at a single institution. Pathol Res Pract. 213:119–125.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Whelan J, McTiernan A, Cooper N, Wong YK,
Francis M, Vernon S and Strauss SJ: Incidence and survival of
malignant bone sarcomas in England 1979–2007. Int J Cancer.
131:E508–E517. 2012. View Article : Google Scholar
|
|
3
|
Huang Q, Ou YS, Tao Y, Yin H and Tu PH:
Apoptosis and autophagy induced by pyropheophorbide-α methyl
ester-mediated photodynamic therapy in human osteosarcoma MG-63
cells. Apoptosis. 21:749–760. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Agostinis P, Berg K, Cengel KA, Foster TH,
Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel
D, et al: Photodynamic therapy of cancer: An update. CA Cancer J
Clin. 61:250–281. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khaled YS, Wright KE, Melcher A and Jayne
D: Anti-cancer effects of oncolytic viral therapy combined with
photodynamic therapy in human pancreatic cancer cell lines. Spring
Meeting for Clinician Scientists in Training 2015. 26–Feb. 2015,
https://doi.org/10.1016/S0140-6736(15)60371-3.
|
|
6
|
Cheng Y, Chang Y, Feng Y, Liu N, Sun X,
Feng Y, Li X and Zhang H: Simulated sunlight-mediated photodynamic
therapy for melanoma skin cancer by
titanium-dioxide-nanoparticle-gold-nanocluster-graphene
heterogeneous nanocomposites. Small. 13:16039352017. View Article : Google Scholar
|
|
7
|
Kuzyniak W, Schmidt J, Glac W, Berkholz J,
Steinemann G, Hoffmann B, Ermilov EA, Gürek AG, Ahsen V, Nitzsche
B, et al: Novel zinc phthalocyanine as a promising photosensitizer
for photodynamic treatment of esophageal cancer. Int J Oncol.
50:953–963. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yano T, Kasai H, Horimatsu T, Yoshimura K,
Teramukai S, Morita S, Tada H, Yamamoto Y, Kataoka H, Kakushima N,
et al: A multicenter phase II study of salvage photodynamic therapy
using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for
local failure after chemoradiotherapy or radiotherapy for
esophageal cancer. Oncotarget. 8:22135–22144. 2017.PubMed/NCBI
|
|
9
|
Luo T, Wilson BC and Lu QB: Evaluation of
one- and two-photon activated photodynamic therapy with
pyropheophorbide-a methyl ester in human cervical, lung and ovarian
cancer cells. J Photochem Photobiol B. 132:102–110. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li KM, Sun X, Koon HK, Leung WN, Fung MC,
Wong RN, Lung ML, Chang CK and Mak NK: Apoptosis and expression of
cytokines triggered by pyropheophorbide-a methyl ester-mediated
photodynamic therapy in nasopharyngeal carcinoma cells. Photodiagn
Photodyn Ther. 3:247–258. 2006. View Article : Google Scholar
|
|
11
|
Tian Y, Leung W, Yue K and Mak N: Cell
death induced by MPPa-PDT in prostate carcinoma in vitro and in
vivo. Biochem Biophys Res Commun. 348:413–420. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tian YY, Hu XY, Leung WN, Yuan HQ, Zhang
LY, Cui FA and Tian X: Investigation of photodynamic effect caused
by MPPa-PDT on breast cancer Investigation of photodynamic effect
caused by MPPa-PDT. Laser Phys Lett. 9:754–758. 2012. View Article : Google Scholar
|
|
13
|
Gilaberte Y, Milla L, Salazar N,
Vera-Alvarez J, Kourani O, Damian A, Rivarola V, Roca MJ, Espada J,
González S, et al: Cellular intrinsic factors involved in the
resistance of squamous cell carcinoma to photodynamic therapy. J
Invest Dermatol. 134:2428–2437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zamarrón A, Lucena SR, Salazar N,
Sanz-Rodríguez F, Jaén P, Gilaberte Y, González S and Juarranz Á:
Isolation and charac-terization of PDT-resistant cancer cells.
Photochem Photobiol Sci. 14:1378–1389. 2015. View Article : Google Scholar
|
|
15
|
Anderson SJ, Wapnir I, Dignam JJ, Fisher
B, Mamounas EP, Jeong JH, Geyer CE Jr, Wickerham DL, Costantino JP
and Wolmark N: Prognosis after ipsilateral breast tumor recurrence
and locoregional recurrences in patients treated by
breast-conserving therapy in five National Surgical Adjuvant Breast
and Bowel Project protocols of node-negative breast cancer. J Clin
Oncol. 27:2466–2473. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang C, Guo LB, Ma JY, Li YM and Liu HM:
Establishment and characterization of a paclitaxel-resistant human
esophageal carcinoma cell line. Int J Oncol. 43:1607–1617. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jeon M, Rahman N and Kim YS:
Cytoprotective effect of Makgeolli lees on paraquat induced
oxidative stress in A549 cells via activation of NRF2 and
antioxidant genes. J Microbiol Biotechnol. 26:277–286. 2016.
View Article : Google Scholar
|
|
18
|
Dean M: ABC transporters, drug resistance,
and cancer stem cells. J Mammary Gland Biol Neoplasia. 14:3–9.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang B, Pan JS, Liu JY, Han SP, Hu G and
Wang B: Effects of chemotherapy and/or radiotherapy on survivin
expression in ovarian cancer. Methods Find Exp Clin Pharmacol.
28:619–625. 2006. View Article : Google Scholar
|
|
20
|
Czabotar PE, Lessene G, Strasser A and
Adams JM: Control of apoptosis by the BCL-2 protein family:
Implications for physiology and therapy. Nat Rev Mol Cell Biol.
15:49–63. 2014. View Article : Google Scholar
|
|
21
|
Restifo NP, Smyth MJ and Snyder A:
Acquired resistance to immunotherapy and future challenges. Nat Rev
Cancer. 16:121–126. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wicki A, Mandalà M, Massi D, Taverna D,
Tang H, Hemmings BA and Xue G: Acquired resistance to clinical
cancer therapy: A Twist in physiological signaling. Physiol Rev.
96:805–829. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Solyanik GI: Multifactorial nature of
tumor drug resistance. Exp Oncol. 32:181–185. 2010.
|
|
24
|
Milla LN, Cogno IS, Rodríguez ME,
Sanz-Rodríguez F, Zamarrón A, Gilaberte Y, Carrasco E, Rivarola VA
and Juarranz A: Isolation and characterization of squamous
carcinoma cells resistant to photodynamic therapy. J Cell Biochem.
112:2266–2278. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tu P, Huang Q, Ou Y, Du X, Li K, Tao Y and
Yin H: Aloe-emodin-mediated photodynamic therapy induces autophagy
and apoptosis in human osteosarcoma cell line MG-63 through the
ROS/JNK signaling pathway. Oncol Rep. 35:3209–3215. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chau LY: Heme oxygenase-1: Emerging target
of cancer therapy. J Biomed Sci. 22:222015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Furfaro AL, Traverso N, Domenicotti C,
Piras S, Moretta L, Marinari UM, Pronzato MA and Nitti M: The
Nrf2/HO-1 axis in cancer cell growth and chemoresistance. Oxid Med
Cell Longev. 2016:19581742016. View Article : Google Scholar
|
|
28
|
Ciesla M, Marona P, Kozakowska M, Jez M,
Seczynska M, Loboda A, Bukowska-Strakova K, Szade A, Walawender M,
Kusior M, et al: Heme oxygenase-1 controls an HDAC4-miR-206 pathway
of oxidative stress in rhabdomyosarcoma. Cancer Res. 76:5707–5718.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lv X, Song DM, Niu YH and Wang BS:
Inhibition of heme oxygenase-1 enhances the chemosensitivity of
laryngeal squamous cell cancer Hep-2 cells to cisplatin. Apoptosis.
21:489–501. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Soares HT, Campos JR, Gomes-da-Silva LC,
Schaberle FA, Dąbrowski JM and Arnaut LG: Pro-oxidant and
antioxidant effects in Photodynamic Therapy: Cells recognize that
not all exogenous ROS are alike. ChemBioChem. 17:836–842. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wright KE, MacRobert AJ and Phillips JB:
Inhibition of specific cellular antioxidant pathways increases the
sensitivity of neurons to meta-tetrahydroxyphenyl chlorin-mediated
photodynamic therapy in a 3D co-culture model. Photochem Photobiol.
88:1539–1545. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tian S, Yong M, Zhu J, Zhang L, Pan L,
Chen Q, Li KT, Kong YH, Jiang Y, Yu TH, et al: Enhancement of the
effect of methyl pyropheophorbide-a-mediated photodynamic therapy
was achieved by increasing ROS via inhibition of Nrf2-HO-1 or
Nrf2-ABCG2 signaling. Anticancer Agents Med Chem. 17:12017.
View Article : Google Scholar
|
|
33
|
Ishikawa T, Nakagawa H, Hagiya Y,
Nonoguchi N, Miyatake S and Kuroiwa T: Key role of human ABC
transporter ABCG2 in photodynamic therapy and photodynamic
diagnosis. Adv Pharmacol Sci. 2010:5873062010.PubMed/NCBI
|
|
34
|
Li C, Guo D, Tang B, Zhang Y, Zhang K and
Nie L: Notch1 is associated with the multidrug resistance of
hypoxic osteosarcoma by regulating MRP1 gene expression. Neoplasma.
63:734–742. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu T, Li Z, Zhang Q, De Amorim Bernstein
K, Lozano-Calderon S, Choy E, Hornicek FJ and Duan Z: Targeting
ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the
CRISPR-Cas9 system to reverse drug resistance. Oncotarget.
7:83502–83513. 2016.PubMed/NCBI
|
|
36
|
Ferrario A, Rucker N, Wong S, Luna M and
Gomer CJ: Survivin, a member of the inhibitor of apoptosis family,
is induced by photodynamic therapy and is a target for improving
treatment response. Cancer Res. 67:4989–4995. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Otto T and Sicinski P: Cell cycle proteins
as promising targets in cancer therapy. Nat Rev Cancer. 17:93–115.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han T, Zhu X, Wang J, Zhao H, Ma Q, Zhao
J, Qiu X and Fan Q: Establishment and characterization of a
cisplatin-resistant human osteosarcoma cell line. Oncol Rep.
32:1133–1139. 2014.PubMed/NCBI
|
|
39
|
Baldea I, Olteanu DE, Bolfa P, Tabaran F,
Ion RM and Filip GA: Melanogenesis and DNA damage following
photodynamic therapy in melanoma with two meso-substituted
porphyrins. J Photochem Photobiol B. 161:402–410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Borgstahl GEO, Brader K, Mosel A, Liu S,
Kremmer E, Goettsch KA, Kolar C, Nasheuer HP and Oakley GG:
Interplay of DNA damage and cell cycle signaling at the level of
human replication protein A. DNA Repair. 21:12–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Casas A, Di Venosa G, Vanzulli S, Perotti
C, Mamome L, Rodriguez L, Simian M, Juarranz A, Pontiggia O, Hasan
T, et al: Decreased metastatic phenotype in cells resistant to
aminolevulinic acid-photodynamic therapy. Cancer Lett. 271:342–351.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Stuckey DW and Shah K: Stem cell-based
therapies for cancer treatment: Separating hope from hype. Nat Rev
Cancer. 14:683–691. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tirino V, Desiderio V, d'Aquino R, De
Francesco F, Pirozzi G, Graziano A, Galderisi U, Cavaliere C, De
Rosa A, Papaccio G, et al: Detection and characterization of
CD133+ cancer stem cells in human solid tumours. PLoS
One. 3:e34692008. View Article : Google Scholar
|
|
44
|
Veselska R, Hermanova M, Loja T, Chlapek
P, Zambo I, Vesely K, Zitterbart K and Sterba J: Nestin expression
in osteosarcomas and derivation of nestin/CD133 positive
osteosarcoma cell lines. BMC Cancer. 8:3002008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
He A, Qi W, Huang Y, Feng T, Chen J, Sun
Y, Shen Z and Yao Y: CD133 expression predicts lung metastasis and
poor prognosis in osteosarcoma patients: A clinical and
experimental study. Exp Ther Med. 4:435–441. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li J, Zhong XY, Li ZY, Cai JF, Zou L, Li
JM, Yang T and Liu W: CD133 expression in osteosarcoma and
derivation of CD133+ cells. Mol Med Rep. 7:577–584.
2013. View Article : Google Scholar
|
|
47
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar
|
|
48
|
Robey RW, Polgar O, Deeken J, To KW and
Bates SE: ABCG2: Determining its relevance in clinical drug
resistance. Cancer Metastasis Rev. 26:39–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ding XW, Wu JH and Jiang CP: ABCG2: A
potential marker of stem cells and novel target in stem cell and
cancer therapy. Life Sci. 86:631–637. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Di Fiore R, Santulli A, Ferrante RD,
Giuliano M, De Blasio A, Messina C, Pirozzi G, Tirino V, Tesoriere
G and Vento R: Identification and expansion of human
osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide
treatment. J Cell Physiol. 219:301–313. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jaggupilli A and Elkord E: Significance of
CD44 and CD24 as cancer stem cell markers: An enduring ambiguity.
Clin Dev Immunol. 2012:7080362012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Spring BQ, Rizvi I, Xu N and Hasan T: The
role of photodynamic therapy in overcoming cancer drug resistance.
Photochem Photobiol Sci. 14:1476–1491. 2015. View Article : Google Scholar : PubMed/NCBI
|
